Meta-Analysis
Copyright ©The Author(s) 2016.
World J Cardiol. Jan 26, 2016; 8(1): 98-111
Published online Jan 26, 2016. doi: 10.4330/wjc.v8.i1.98
Figure 1
Figure 1 Flow-chart of the study selection process. IABP: Intra-aortic balloon pump; PLVADs: Percutaneous left ventricular assist devices; ECMO: Extracorporeal membrane oxygenation.
Figure 2
Figure 2 Meta-analysis on risk ratio of inhospital mortality between the patients with intra-aortic balloon pump vs medical therapy.
Figure 3
Figure 3 Intra-aortic balloon pump vs medical therapy: Trial Sequential Analysis on inhospital mortality. IABP: Intra-aortic balloon pump.
Figure 4
Figure 4 Meta-analysis on risk ratio of late mortality between the patients with intra-aortic balloon pump vs medical therapy.
Figure 5
Figure 5 Meta-analysis on risk ratio of inhospital mortality between the patients with percutaneous left ventricular assist devices vs intra-aortic balloon pump. IABP: Intra-aortic balloon pump; PLVADs: Percutaneous left ventricular assist devices.
Figure 6
Figure 6 Meta-analysis on risk ratio of inhospital mortality between the patients with extracorporeal membrane oxygenation plus Intra-aortic balloon pump vs intra-aortic balloon pump or extracorporeal membrane oxygenation alone. IABP: Intra-aortic balloon pump; ECMO: Extracorporeal membrane oxygenation.
Figure 7
Figure 7 Extracorporeal membrane oxygenation plus Intra-aortic balloon pump support vs Intra-aortic balloon pump alone: Trial Sequential Analysis on inhospital mortality. IABP: Intra-aortic balloon pump; ECMO: Extracorporeal membrane oxygenation.